Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis

National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't Child Infant preschool Clinical Trial Randomized Controlled Trial Double-Blind Method placebos severity of illness index respiratory syncytial virus infections / immunology respiratory syncytial virus infections / prevention & control* respiratory syncytial viruses / isolation & purification controlled clinical trial cystic fibrosis / complications vaccines viral vaccines / therapeutic use hn protein* viral envelope proteins respiratory syncytial viruses / immunology child nutritional physiological phenomena respiratory syncytial virus infections / complications pmid:8684872 doi:10.1097/00006454-199601000-00006 p a piedra s grace p w hiatt cystic fibrosis / virology* environment respiratory syncytial viruses / chemistry vaccination* synthetic / adverse effects synthetic / immunology synthetic / therapeutic use viral proteins / immunology* viral vaccines / adverse effects viral vaccines / immunology